113 related articles for article (PubMed ID: 1715200)
1. The serine antiprotease aprotinin (Trasylol): a novel approach to reducing postoperative bleeding.
Royston D
Blood Coagul Fibrinolysis; 1990; 1(1):55-69. PubMed ID: 1715200
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological properties of aprotinin and its therapeutic use in heart surgery].
Carrera A; Fernández P; García del Valle S; de la Quintana B; Martínez MV
Rev Esp Anestesiol Reanim; 1993; 40(5):292-9. PubMed ID: 7504313
[TBL] [Abstract][Full Text] [Related]
3. High-dose aprotinin (trasylol) in reducing bleeding and protecting lung function in potential bleeders undergoing cardiopulmonary bypass.
Liu B; Belboul A; al-Khaja N; Dernevik L; Raberts D; William-Olsson G
Chin Med J (Engl); 1991 Dec; 104(12):980-5. PubMed ID: 1723673
[TBL] [Abstract][Full Text] [Related]
4. The effect of aprotinin (trasylol) on postoperative bleeding in cyanotic congenital heart disease.
Hazan E; Paşaoğlu I; Demircin M; Bozer AY
Turk J Pediatr; 1991; 33(2):99-109. PubMed ID: 1726922
[TBL] [Abstract][Full Text] [Related]
5. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin in cardiac surgery.
Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
[TBL] [Abstract][Full Text] [Related]
7. The management of bleeding following surgery requiring hypothermic circulatory arrest.
Rooney SJ; Bonser RS
J Card Surg; 1997; 12(2 Suppl):238-42. PubMed ID: 9271752
[TBL] [Abstract][Full Text] [Related]
8. [Aprotinin in open heart operations].
Hack G; Kirchhoff PG; Popov-Cenić S; Kulzer R; Schlemminger B; Piepho A
Med Welt; 1983 Jun; 34(25-26):726-31. PubMed ID: 6193394
[No Abstract] [Full Text] [Related]
9. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action.
McEvoy MD; Reeves ST; Reves JG; Spinale FG
Anesth Analg; 2007 Oct; 105(4):949-62. PubMed ID: 17898372
[TBL] [Abstract][Full Text] [Related]
10. [Reducing bleeding during extracorporeal circulation interventions by high doses of aprotinin].
Gherli T; Porcu A; Padua G; Marongiu GM; Antona C; Alamanni F; Bacciu PP
Minerva Cardioangiol; 1992 Apr; 40(4):121-6. PubMed ID: 1382251
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of aprotinin use during cardiac surgery.
Kristeller JL; Roslund BP; Stahl RF
Pharmacotherapy; 2008 Jan; 28(1):112-24. PubMed ID: 18154481
[TBL] [Abstract][Full Text] [Related]
13. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
15. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
Lindvall G; Sartipy U; van der Linden J
Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
[TBL] [Abstract][Full Text] [Related]
17. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of aprotinin in arterial switch operations in infants.
Murugesan C; Banakal SK; Garg R; Keshavamurthy S; Muralidhar K
Anesth Analg; 2008 Sep; 107(3):783-7. PubMed ID: 18713883
[TBL] [Abstract][Full Text] [Related]
20. The platelet componentof hemostasis in aortic surgery.
Charnaia MA; Morozov IuA; Gladysheva VG; Belov IuV; Isaeva AM
Angiol Sosud Khir; 2005; 11(3):7-12. PubMed ID: 16439943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
